Earnings Feed
Start Free
Home/Filings/4/0001140361-10-042111
4//SEC Filing

Cheong Kwang Soo 4

Accession 0001140361-10-042111

CIK 0001228627other
View on SEC.govCompany Profile

Filed

Oct 24, 8:00 PM ET

Accepted

Oct 25, 10:55 AM ET

Size

11.3 KB

Accession

0001140361-10-042111

Insider Transaction Report

Form 4
Period: 2010-06-14
REXAHN PHARMACEUTICALS, INC.RNN
Cheong Kwang Soo
Director
Transactions
  • Award

    Stock Options (right-to-buy)

    2010-06-14+20,000→ 20,000 total
    Exercise: $1.17Exp: 2020-06-14→ Common Stock (20,000 underlying)
Holdings

  • Common Stock

    3,000

  • Stock Options (right-to-buy)

    Exercise: $1.28From: 2010-06-01Exp: 2019-06-01→ Common Stock (20,000 underlying)
    20,000

  • Stock Options (right-to-buy)

    Exercise: $1.40From: 2008-06-11Exp: 2017-06-11→ Common Stock (20,000 underlying)
    20,000

  • Stock Options (right-to-buy)

    Exercise: $3.24From: 2009-06-30Exp: 2018-06-30→ Common Stock (20,000 underlying)
    20,000

  • Stock Options (right-to-buy)

    Exercise: $1.20From: 2007-05-01Exp: 2016-05-01→ Common Stock (20,000 underlying)
    20,000
Footnotes (1)
  • [F1]These options vest and become exercisable in full on June 14, 2011.

Documents

1 file

Issuer

REXAHN PHARMACEUTICALS, INC.

CIK 0001228627

→
Entity typeother

Related Parties

1
  • filerCIK 0001361686

Filing Metadata

Form type
4
Filed
Oct 24, 8:00 PM ET
Accepted
Oct 25, 10:55 AM ET
Size
11.3 KB
View on SEC.gov